MDR1 gene polymorphisms are associated with neuropsychiatric adverse effects of mefloquine.
Aarnoudse AL, van Schaik RH, Dieleman J, Molokhia M, van Riemsdijk MM, Ligthelm RJ, Overbosch D, van der Heiden IP, Stricker BH.
Aarnoudse AL, et al. Among authors: van schaik rh, van riemsdijk mm, van der heiden ip.
Clin Pharmacol Ther. 2006 Oct;80(4):367-74. doi: 10.1016/j.clpt.2006.07.003.
Clin Pharmacol Ther. 2006.
PMID: 17015054